The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumShort Ideas - Shares of Pain Therapeutics (NASDAQ:PTIE) are off 25% as partner Pfizer (NYSE:PFE) noted Thursday on its earnings call that Remoxy, PTIE’s lead product, is a … Continue Reading
Read nowLong Ideas - Oncology-focused ArQule, Inc. (NASDAQ:ARQL) reported third quarter financial results on Thursday morning, noting that cash, equivalents, and marketable investments totaled $140M on Sept. 30, and … Continue Reading
Read nowLong Ideas - Merge Healthcare (NASDAQ:MRGE) reported adjusted 3Q 2012 revenues and EPS of $61.0 million and $0.01, compared to Wall St. Consensus expectations of $62.9 million and … Continue Reading
Read nowLong Ideas - One of the most pressing issues that the market faces today is what kind of impact the fiscal cliff will have on companies in the … Continue Reading
Read nowQuick Picks - Chalk another “nuc” up to the FDA’s growing list of safety-related development interruptions. On Tuesday, BioCryst Pharmaceuticals (NASDAQ:BCRX) announced that it has withdrawn an Investigational … Continue Reading
Read nowLong Ideas - Navidea Biopharmaceuticals (NASDAQ:NAVB) announced that on October 30th it resubmitted its new drug application (NDA) for Lymphoseek in response to the FDA’s Complete Response Letter … Continue Reading
Read nowLong Ideas - The biotechnology sector can be broken up, at its simplest, into two distinct groups: the Big 4, and every other company. The Big 4 are … Continue Reading
Read now
